Two different measurements
Peptide purity versus peptide content
A high chromatographic purity result and a measured amount of peptide answer different questions. To interpret a COA, first check whether its percentage refers to peak area, mass fraction or another reporting basis.
Chromatographic purity compares detected signals
For a reported HPLC-UV area percentage, the integrated signal assigned to the main peak is compared with the included chromatographic signal. The method’s separation, detector settings and integration rules define what enters that comparison.
A 99% area result therefore describes the relative signal in that analysis. It does not, by itself, show that a vial contains its labelled peptide mass. The NIST reference-material example below distinguishes area purity from mass purity.
Content describes an amount on a stated basis
A quantitative content measurement needs an appropriate calibration or other quantitative approach. A published NIST/USP inter-laboratory study compared calibrated HPLC assay, quantitative NMR and amino acid analysis for oxytocin. These are measurement examples, not a statement that each technique is available for your sample.
Ask for the result basis: milligrams per submitted vial, concentration in a prepared solution or peptide mass fraction are different quantities. Preparation, dilution and the reference material matter when translating the measurement into the reported unit.
Powder mass and peptide mass can differ
A weighed solid need not consist entirely of the target peptide. For example, the BIPM C-peptide comparison report linked below considers water, counterions and peptide-related impurities when assigning a peptide mass fraction. Which components are relevant depends on the material.
Do not multiply a gross powder weight by an HPLC area percentage and present the result as a measured peptide amount. Those two measurements do not establish all the terms needed for that calculation.
Choose the test for the claim you need to check
For a question about a chromatographic impurity profile, discuss purity testing. For a question about the amount of the target peptide in the submitted material, discuss a quantitative content assay. For a question about the named compound, discuss identity testing.
Share the label claim, formulation and sample format with intake. Confirm the available method, reporting basis and sample requirements before shipping.
- Read both the result and its units.
- Keep purity, identity and content findings separate.
- Ask whether a blend or modified peptide requires a different scope.